Harvest Portfolios Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$54M Buy
1,264,163
+347,182
+38% +$18.9M 0.76% 42
2026
Q1
$57.5M Buy
916,981
+319,640
+54% +$25.6M 0.95% 33
2025
Q4
$57M Buy
597,341
+34,598
+6% +$3.39M 0.99% 34
2025
Q3
$54.9M Buy
562,743
+13,141
+2% +$1.36M 1.01% 34
2025
Q2
$59M Buy
549,602
+6,234
+1% +$631K 1.37% 18
2025
Q1
$54.8M Sell
543,368
-32,607
-6% -$3.28M 1.62% 19
2024
Q4
$51.4M Sell
575,975
-174,241
-23% -$15.3M 1.72% 19
2024
Q3
$62.9M Buy
750,216
+54,371
+8% +$4.29M 2.09% 6
2024
Q2
$53.6M Sell
695,845
-146,855
-17% -$10.7M 2.05% 12
2024
Q1
$57.7M Sell
842,700
-133,410
-14% -$8.58M 2.25% 6
2023
Q4
$56.4M Sell
976,110
-38,639
-4% -$2.06M 2.39% 8
2023
Q3
$53.6M Buy
1,014,749
+20,969
+2% +$1.1M 2.53% 6
2023
Q2
$53.8M Sell
993,780
-37,081
-4% -$1.94M 2.47% 4
2023
Q1
$51.6M Buy
1,030,861
+9,345
+0.9% +$440K 2.53% 8
2022
Q4
$47.3M Buy
+1,021,516
New +$44.2M 2.72% 11

Other funds holding BSX

Harvest Portfolios Group's BSX Position: Q2 2026 in Review

Harvest Portfolios Group increased its Boston Scientific (BSX) stake by 38% in Q2 2026, buying an estimated $18.9M and bringing the position to 1,264,163 shares worth $54M. The position accounts for 0.76% of the portfolio, ranked #42.

Harvest Portfolios Group first reported a position in BSX in Q4 2022 and has held it in 15 quarters since. The position peaked at $62.9M in Q3 2024. 1,474 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Harvest Portfolios Group held 1,264,163 shares of Boston Scientific worth $54M as of Q2 2026.
  • Harvest Portfolios Group bought 347,182 Boston Scientific shares in Q2 2026, an estimated $18.9M.
  • Boston Scientific made up 0.76% of Harvest Portfolios Group's portfolio in Q2 2026, its #42 holding.
  • Harvest Portfolios Group first reported a position in Boston Scientific in Q4 2022 and has held it in 15 quarters since.
  • Harvest Portfolios Group's Boston Scientific position peaked at $62.9M in Q3 2024.
  • 1,474 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Harvest Portfolios Group's 13F filing for Q2 2026, filed 13 Aug 2026.